CAS No. |
874485-32-2 |
中文名称 |
(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4,6-二醇 |
英文名称 |
(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol |
别名 |
(25RS)-Ruscogenin;Spirost-5-ene-1,3-diol, (1β,3β)- (9CI);Mammalian target of Rapamycin,Inhibitor,Phosphoinositide 3-kinase,mTOR,25(R,S) Ruscogenin,inhibit,Akt,25(R,S)-Ruscogenin,PI3K,25(R,S)Ruscogenin,Protein kinase B,PKB;25(R,S)-Ruscogenin, 10 mM in DMSO;(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-Tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol |
标准英文名 |
(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol |
MDL No. |
- |
分子式 |
C27H42O4 |
分子量 |
430.63
|
精确分子量 |
430.31
|
SMILES |
CC1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C |
标准SMILES |
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)C[C@@H](O)[C@@]43C)[C@@H]1C[C@@H]1O[C@]3(CCC(C)CO3)[C@@H](C)[C@H]21 |
用途 |
(25RS)-Ruscogenin inhibits hepatocellular carcinoma metastasis by modulating the PI3K/Akt/mTOR signaling pathway and downregulating the expression of MMP-2, MMP-9, uPA, VEGF, and HIF-1α; it also alleviates LPS-induced pulmonary endothelial cell apoptosis by inhibiting the TLR4 signaling pathway. |
InChIKey |
QMQIQBOGXYYATH-ZBTLHKOBSA-N |